Long Lasting Organic Semiochemical Formulation to Effectively Manage Blood Sucking Diptera.
持久的有机化学制剂可有效控制吸血双翅目。
基本信息
- 批准号:10565865
- 负责人:
- 金额:$ 100万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-12 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptionAdultAedesAirAnopheles GenusAreaBacillus thuringiensisBacteriaBacterial Artificial ChromosomesBedsBehaviorBiologicalBloodBlood-Borne PathogensBrazilBreedingChemicalsCollectionConsumptionControl GroupsCulex (Genus)CulicidaeDataDengueDipteraDrynessEnsureEnvironmentExposure toFemaleFloodsFoodFormulationFosteringFriendsGrantHabitatsHomeHuman BitesInfectionIngestionInsecticidesInternationalInterventionInvadedJuvenile HormonesLarvaLeftLifeMalariaMarketingMeasuresMethopreneMosquito ControlMosquito-borne infectious diseaseNamesNatureOrganophosphatesOvipositionPartner in relationshipPenetrationPersonsPest ControlPhasePilot ProjectsPopulationPredispositionProcessRainReadinessRegulationResearchResidual stateResistanceResistance developmentRiskRisk ReductionRunningSafetySalesSedimentation processSemiochemicalsSiteSourceStimulantSurfaceTanzaniaTechnologyTemephosToxinUnited States National Institutes of HealthVariantVectorial capacityWaterWest Nile virusZIKAcommercializationcontrolled releasedesigndisease transmissionefficacy trialeggfeedinglarval controlmalaria mosquitomalaria transmissionmortalitynoveloutbreak controlpreferencepreventprogramspyrethroidresearch and developmentsuccesssuckingtransmission processvectorvector management strategiesvector mosquito
项目摘要
Project Summary:
SPLAT BAC Plus is a unique controlled-release larvicide designed to suppress populations of multiple species of
mosquitoes, such as those that transmit malaria, dengue, and West Nile virus (WNV). This CRP proposal seeks
to establish SPLAT BAC Plus as an effective, economically viable control strategy for use in integrated vector
management (IVM) programs and for control of nuisance mosquitoes around the globe. SPLAT BAC Plus has
several advantages over previous larvicides: 1) It contains a combination of larvicidal agents with different modes
of action: Bacillus thuringiensis israelensis (Bti), B. sphaericus (Bsp) [recently renamed Lysinibacillus
sphaericus]—two bacteria that destroy the gut of mosquitoes that ingest them—and an insect growth regulator
(IGR), such as methoprene or pyriproxyfen, that prevents larvae from developing into adults. This combination
drastically reduces the risk of resistance compared to single-action larvicides. While there are products on the
market combining Bti and Bsp, the inclusion of an IGR in SPLAT BAC Plus will further inhibit the development
of resistance and greatly extend the field life of the larvicide. 2) SPLAT BAC Plus includes components that
promote larval attraction and feeding on the formulation—intensifying their exposure to the Bti, Bsp, and IGR
contained within it—and oviposition attractants (attractants for egg-laying females). As point sources of SPLAT
BAC Plus float at the surface of treated water, these attractants are released into the air, enticing female
mosquitoes to lay their eggs preferentially at that site. 3) SPLAT BAC Plus can be applied to potential larval
habitats under dry conditions ahead of rainfall, a major advantage over most larvicides, which must be applied
shortly after these sites fill with water to catch mosquito larvae at a susceptible stage. 4) Following application,
SPLAT BAC Plus cures and becomes rainfast, becoming activated when the surfaces are submerged for a few
days, detaching and floating to the water's surface and releasing its attractants. After this point, SPLAT BAC Plus
remains buoyant and effective for up to 5 months, considerably longer than the 1–2 week-field life associated
with older Bti/Bsp larvicides. 5) SPLAT BAC Plus contains environmentally safe larvicides and semiochemical
attractants incorporated in an inert matrix composed of food-safe ingredients. To achieve global
commercialization of SPLAT BAC Plus, ISCA Technologies intends to pursue the following Specific Aims: 1)
Obtain the required regulatory approvals to begin sales of SPLAT BAC Plus in the US and begin penetration of
target international markets (e.g., Brazil, Tanzania); 2) Foster consumer support and buy-in via demonstration
trials of SPLAT BAC Plus with targeted distributors of mosquito control products, pest control operators (PCOs),
and mosquito control districts; and 3) Utilize SPLAT BAC Plus to launch a more diversified product line of
mosquito control technologies, designed to conform to the different needs of various mosquito control groups
and consumers, such as varying target species, environmental and safety concerns, and difficulties with
resistance to different control agents.
项目摘要:
Splat Bac Plus是一种独特的控制释放幼虫,旨在抑制多种种群的种群
蚊子,例如传播疟疾,登革热和西尼罗河病毒(WNV)的蚊子。这个CRP提案寻求
建立SPLAT BAC加作为一种有效的,经济上可行的控制策略,用于综合向量
管理(IVM)计划,以控制全球的滋扰蚊子。 Splat Bac Plus具有
比以前的幼虫的几个优点:1)它包含具有不同模式的幼虫剂的组合
作用:苏云金芽孢杆菌以色列人(BTI),B。sphaericus(BSP)[最近更名为Lysinibacillus
Sphaericus] - 两种细菌破坏了摄取它们的蚊子的肠道 - 和一个绝缘生长调节剂
(IGR),例如Methodprene或pyryfen,可防止幼虫发展成为成年人。这种组合
与单一作用幼虫相比,大幅度降低了耐药性的风险。虽然有产品
将BTI和BSP结合在一起的市场,将IGR纳入Splat Bac Plus将进一步抑制开发
抗性和巨大的延长了幼虫的野生寿命。 2)Splat Bac Plus包括
促进幼虫吸引力并以公式为食 - 强调其暴露于BTI,BSP和IGR
其中包含在其中 - 产卵吸引剂(卵子雌性的吸引剂)。作为Splat的点源
Bac Plus在处理水面的表面上漂浮,这些景点被释放到空中,诱使女性
蚊子优先在该地点产卵。 3)Splat Bac Plus可以应用于潜在的幼虫
在降雨前的干燥条件下的栖息地,这是大多数幼虫的主要优势,必须应用于
这些地点充满水以在易感阶段捕获蚊子幼虫。 4)申请后,
Splat Bac Plus治疗疗法并变成雨水,当表面被浸入少量时会激活
天,脱落并漂浮到水面并释放其景点。此后,Splat Bac Plus
保持浮力且有效长达5个月,考虑比与1-2个周场相关的生活更长
较旧的BTI/BSP幼虫。 5)Splat Bac Plus包含环境安全的幼虫和半化学
吸引剂掺入由食品安全成分组成的惰性基质中。实现全球
Splat BAC Plus的商业化,ISCA技术打算追求以下特定目的:1)
获得所需的监管部门批准,以开始在美国开始销售Splat Bac Plus并开始渗透
目标国际市场(例如,巴西,坦桑尼亚); 2)培养消费者的支持和通过演示来买入
Splat BAC Plus的试验与蚊子控制产品的有针对性分销商,害虫控制操作员(PCOS),
和蚊子控制区; 3)利用Splat Bac Plus推出更多元化的产品线
蚊子控制技术,旨在符合各种蚊子对照组的不同需求
和消费者,例如不同的目标物种,环境和安全问题以及困难
对不同控制剂的抗性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Agenor Mafra-Neto其他文献
Agenor Mafra-Neto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Agenor Mafra-Neto', 18)}}的其他基金
Long Lasting Organic Semiochemical Formulation to Effectively Manage Blood Sucking Diptera.
持久的有机化学制剂可有效控制吸血双翅目。
- 批准号:
10383803 - 财政年份:2017
- 资助金额:
$ 100万 - 项目类别:
Long Lasting Organic Semiochemical Formulation to Effectively Manage Blood Sucking Diptera
持久的有机化学制剂可有效控制吸血双翅目
- 批准号:
9409577 - 财政年份:2017
- 资助金额:
$ 100万 - 项目类别:
Long Lasting Organic Semiochemical Formulation to Effectively Manage Blood Sucking Diptera
持久的有机化学制剂可有效控制吸血双翅目
- 批准号:
9527066 - 财政年份:2017
- 资助金额:
$ 100万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Disrupting the mosquito larval midgut using novel pH responsive compounds
使用新型 pH 响应化合物破坏蚊子幼虫中肠
- 批准号:
10722596 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Juvenile hormone transporters in disease vector physiology
疾病媒介生理学中的保幼激素转运蛋白
- 批准号:
10658269 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
The development of biorational pesticides targeting lncRNAs in adult female Aedes aegypti mosquitoes
针对成年雌性埃及伊蚊 lncRNA 的生物合理农药的开发
- 批准号:
10742558 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Development of a novel gel bait for the control of mosquitoes in urban environments
开发用于控制城市环境中蚊子的新型凝胶诱饵
- 批准号:
10478531 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
How can mosquitoes develop and reproduce in the complete absence of juvenile hormone?
在完全没有保幼激素的情况下,蚊子如何发育和繁殖?
- 批准号:
10554310 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别: